TRANSITION THERAPEUTICS INC. TTHI (NASDAQ)

$ 2.29
12/04/2008 24:00
Sponsored by
Click here!
Change: unch (unch%)
Volume: 15,750

Avg. Volume: 86527
P/E Ratio: 0
EPS (Annual): -0.50
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 23,200
Institutional Shareholders: 70.27%
Last: 2.29
Change: unch (unch%)
Prev. Close: 2.29
Open: 2.09
Day's Range: 2.08 - 2.29
52wk Range: 2.00 - 14.10
Market Value: 50,610
Beta:
12-month EPS Change: 0.00%
Total Return Last 12 Months: -76.32%
Total Return Last 3 Years: -125.16%
Total Return Last 5 Years: -84.09%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on TTHI
Alert me Subscribe

Transition Therapeutics CFO adds president role

(NEW YORK)Biopharmaceutical company Transition Therapeutics Inc. said Thursday it named Chief Financial Officer Elie Farah to the additional role of president. The company also named Nicole ...READ MORE
Jul 03, 2008 8:15AM
Keywords: TTHI
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN INC. +12.10 56.34
GILEAD SCIENCES -8.20 45.55
CELGENE CORPORA -16.00 52.78
GENENTECH INC -1.40 73.65
GENZYME CORPORA -21.90 61.21